CVRX
CVRx, Inc.
Medical - Devices
Market Cap$192M
5Y Perf.-75.6%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
CVRX vs LFST vs LIVN vs ACHC
Revenue, margins, valuation, and 5-year total return — side by side.
LFST
LifeStance Health Group, Inc.
Medical - Care Facilities
Market Cap$3.43B
5Y Perf.-72.4%
LIVN
LivaNova PLC
Medical - Devices
Market Cap$3.88B
5Y Perf.-14.6%
ACHC
Acadia Healthcare Company, Inc.
Medical - Care Facilities
Market Cap$2.25B
5Y Perf.-59.9%
CVRX vs LFST vs LIVN vs ACHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CVRX | LFST | LIVN | ACHC |
|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Care Facilities | Medical - Devices | Medical - Care Facilities |
| Market Cap | $192M | $3.43B | $3.88B | $2.25B |
| Revenue (TTM) | $56M | $1.49B | $1.43B | $3.37B |
| Net Income (TTM) | $-52M | $23M | $107M | $-1.11B |
| Gross Margin | 85.0% | 21.7% | 67.5% | 56.2% |
| Operating Margin | -90.0% | 3.0% | 13.4% | 11.7% |
| Forward P/E | — | 121.1x | 16.9x | 16.7x |
| Total Debt | $51M | $194M | $473M | $2.65B |
| Cash & Equiv. | $76M | $249M | $636M | $133M |
CVRX vs LFST vs LIVN vs ACHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CVRX
LFST
LIVN
ACHC
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| CVRx, Inc. (CVRX) | 100 | 24.4 | -75.6% |
| LifeStance Health G… (LFST) | 100 | 27.6 | -72.4% |
| LivaNova PLC (LIVN) | 100 | 85.4 | -14.6% |
| Acadia Healthcare C… (ACHC) | 100 | 40.1 | -59.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CVRX vs LFST vs LIVN vs ACHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: LIVN leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Acadia Healthcare Company, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. LFST also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CVRX
CVRx, Inc.
The Secondary Option
CVRX lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: healthcare exposure
LFST
LifeStance Health Group, Inc.
The Growth Play
LFST is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 13.9%, EPS growth 113.3%, 3Y rev CAGR 18.3%
- Lower volatility, beta 1.20, Low D/E 12.8%, current ratio 1.65x
- 13.9% revenue growth vs ACHC's 5.0%
Best for: growth exposure and sleep-well-at-night
LIVN
LivaNova PLC
The Long-Run Compounder
LIVN carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 46.2% 10Y total return vs ACHC's -58.5%
- 7.5% margin vs CVRX's -92.9%
- +63.0% vs CVRX's -2.1%
- 4.2% ROA vs CVRX's -46.7%, ROIC 11.5% vs -256.7%
Best for: long-term compounding
ACHC
Acadia Healthcare Company, Inc.
The Income Pick
ACHC is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.84
- Beta 0.84, current ratio 1.55x
- Lower P/E (16.7x vs 121.1x)
- Beta 0.84 vs CVRX's 1.63, lower leverage
Best for: income & stability and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | LFST | 13.9% revenue growth vs ACHC's 5.0% |
| Value | ACHC | Lower P/E (16.7x vs 121.1x) |
| Quality / Margins | LIVN | 7.5% margin vs CVRX's -92.9% |
| Stability / Safety | ACHC | Beta 0.84 vs CVRX's 1.63, lower leverage |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | LIVN | +63.0% vs CVRX's -2.1% |
| Efficiency (ROA) | LIVN | 4.2% ROA vs CVRX's -46.7%, ROIC 11.5% vs -256.7% |
CVRX vs LFST vs LIVN vs ACHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
FY 2025
FY 2025
CVRX vs LFST vs LIVN vs ACHC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLLIVNLAGGINGLFST
Who Leads Where
LIVN leads in 3 of 6 categories
ACHC leads 1 • CVRX leads 0 • LFST leads 0 • 1 tied
Explore the data ↓LFSTLifeStance Health Gro…
0leads
CVRXCVRx, Inc.
0leads
ACHCAcadia Healthcare Com…
1leads
LIVNLivaNova PLC
3leads
6 Total Categories
CATEGORYLEADERvs ACHCvs CVRXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
LIVN3/6
Valuation MetricsMultiples, price ratios, and targets
ACHC4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
LIVN6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
LIVN5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
LIVN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACHC is the larger business by revenue, generating $3.4B annually — 60.2x CVRX's $56M. LIVN is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to CVRX's -92.9%. On growth, LFST holds the edge at +21.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $56M | $1.5B | $1.4B | $3.4B |
| EBITDAEarnings before interest/tax | -$50M | $100M | $220M | $588M |
| Net IncomeAfter-tax profit | -$52M | $23M | $107M | -$1.1B |
| Free Cash FlowCash after capex | -$39M | $179M | $161M | -$215M |
| Gross MarginGross profit ÷ Revenue | +85.0% | +21.7% | +67.5% | +56.2% |
| Operating MarginEBIT ÷ Revenue | -90.0% | +3.0% | +13.4% | +11.7% |
| Net MarginNet income ÷ Revenue | -92.9% | +1.6% | +7.5% | -32.8% |
| FCF MarginFCF ÷ Revenue | -69.7% | +12.0% | +11.2% | -6.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.8% | +21.2% | +14.3% | +7.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.0% | — | +106.7% | -49.8% |
LIVN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
ACHC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than LFST's 42.0x.
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| Market CapShares × price | $192M | $3.4B | $3.9B | $2.3B |
| Enterprise ValueMkt cap + debt − cash | $167M | $3.4B | $3.7B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | -3.59x | 442.50x | -15.94x | -2.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 121.07x | 16.92x | 16.75x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 41.98x | 15.40x | 8.27x |
| Price / SalesMarket cap ÷ Revenue | 3.38x | 2.41x | 2.79x | 0.68x |
| Price / BookPrice ÷ Book value/share | 4.86x | 2.28x | 3.22x | 1.04x |
| Price / FCFMarket cap ÷ FCF | — | 31.20x | 22.40x | — |
ACHC leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
LIVN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LIVN delivers a 9.1% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-108 for CVRX. LFST carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVRX's 1.29x. On the Piotroski fundamental quality scale (0–9), LFST scores 7/9 vs CVRX's 4/9, reflecting strong financial health.
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -108.3% | +1.6% | +9.1% | -40.9% |
| ROA (TTM)Return on assets | -46.7% | +1.1% | +4.2% | -18.6% |
| ROICReturn on invested capital | -2.6% | +1.2% | +11.5% | +5.9% |
| ROCEReturn on capital employed | -47.9% | +1.3% | +10.2% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.29x | 0.13x | 0.39x | 1.24x |
| Net DebtTotal debt minus cash | -$25M | -$55M | -$162M | $2.5B |
| Cash & Equiv.Liquid assets | $76M | $249M | $636M | $133M |
| Total DebtShort + long-term debt | $51M | $194M | $473M | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | -7.79x | 3.30x | 3.98x | -5.99x |
LIVN leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
LIVN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIVN five years ago would be worth $8,546 today (with dividends reinvested), compared to $2,614 for CVRX. Over the past 12 months, LIVN leads with a +63.0% total return vs CVRX's -2.1%. The 3-year compound annual growth rate (CAGR) favors LIVN at 14.6% vs ACHC's -29.2% — a key indicator of consistent wealth creation.
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.1% | +27.2% | +17.0% | +71.2% |
| 1-Year ReturnPast 12 months | -2.1% | +60.6% | +63.0% | +1.2% |
| 3-Year ReturnCumulative with dividends | -40.4% | +4.1% | +50.5% | -64.5% |
| 5-Year ReturnCumulative with dividends | -73.9% | -59.6% | -14.5% | -61.8% |
| 10-Year ReturnCumulative with dividends | -73.9% | -59.6% | +46.2% | -58.5% |
| CAGR (3Y)Annualised 3-year return | -15.8% | +1.4% | +14.6% | -29.2% |
LIVN leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — LFST and ACHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACHC is the less volatile stock with a 0.84 beta — it tends to amplify market swings less than CVRX's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LFST currently trades 99.6% from its 52-week high vs CVRX's 64.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.41x | 1.06x | 1.33x | 0.82x |
| 52-Week HighHighest price in past year | $11.30 | $8.89 | $71.92 | $30.20 |
| 52-Week LowLowest price in past year | $4.30 | $3.74 | $39.36 | $11.43 |
| % of 52W HighCurrent price vs 52-week peak | +64.8% | +99.6% | +98.6% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 60.4 | 57.6 | 46.2 |
| Avg Volume (50D)Average daily shares traded | 249K | 2.9M | 808K | 3.1M |
Evenly matched — LFST and ACHC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CVRX as "Buy", LFST as "Buy", LIVN as "Buy", ACHC as "Buy". Consensus price targets imply 36.6% upside for CVRX (target: $10) vs 4.6% for ACHC (target: $26).
| Metric | CVRXCVRx, Inc. | LFSTLifeStance Health… | LIVNLivaNova PLC | ACHCAcadia Healthcare… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $10.00 | $9.30 | $79.25 | $25.59 |
| # AnalystsCovering analysts | 7 | 11 | 14 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.1% | +2.2% |
Insufficient data to determine a leader in this category.
Key Takeaway
LIVN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACHC leads in 1 (Valuation Metrics). 1 tied.
Best OverallLivaNova PLC (LIVN)Leads 3 of 6 categories
Loading custom metrics...
CVRX vs LFST vs LIVN vs ACHC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CVRX or LFST or LIVN or ACHC a better buy right now?
For growth investors, LifeStance Health Group, Inc.
(LFST) is the stronger pick with 13. 9% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). LifeStance Health Group, Inc. (LFST) offers the better valuation at 442. 5x trailing P/E (121. 1x forward), making it the more compelling value choice. Analysts rate CVRx, Inc. (CVRX) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CVRX or LFST or LIVN or ACHC?
On forward P/E, Acadia Healthcare Company, Inc.
is actually cheaper at 16. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CVRX or LFST or LIVN or ACHC?
Over the past 5 years, LivaNova PLC (LIVN) delivered a total return of -14.
5%, compared to -73. 9% for CVRx, Inc. (CVRX). Over 10 years, the gap is even starker: LIVN returned +48. 1% versus CVRX's -75. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CVRX or LFST or LIVN or ACHC?
By beta (market sensitivity over 5 years), Acadia Healthcare Company, Inc.
(ACHC) is the lower-risk stock at 0. 82β versus CVRx, Inc. 's 1. 41β — meaning CVRX is approximately 71% more volatile than ACHC relative to the S&P 500. On balance sheet safety, LifeStance Health Group, Inc. (LFST) carries a lower debt/equity ratio of 13% versus 129% for CVRx, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CVRX or LFST or LIVN or ACHC?
By revenue growth (latest reported year), LifeStance Health Group, Inc.
(LFST) is pulling ahead at 13. 9% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: LifeStance Health Group, Inc. grew EPS 113. 3% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, CVRX leads at 36. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CVRX or LFST or LIVN or ACHC?
LifeStance Health Group, Inc.
(LFST) is the more profitable company, earning 0. 7% net margin versus -94. 1% for CVRx, Inc. — meaning it keeps 0. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIVN leads at 14. 4% versus -90. 5% for CVRX. At the gross margin level — before operating expenses — CVRX leads at 85. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CVRX or LFST or LIVN or ACHC more undervalued right now?
On forward earnings alone, Acadia Healthcare Company, Inc.
(ACHC) trades at 16. 7x forward P/E versus 121. 1x for LifeStance Health Group, Inc. — 104. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVRX: 36. 6% to $10. 00.
08Which pays a better dividend — CVRX or LFST or LIVN or ACHC?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CVRX or LFST or LIVN or ACHC better for a retirement portfolio?
For long-horizon retirement investors, Acadia Healthcare Company, Inc.
(ACHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82)). Both have compounded well over 10 years (ACHC: -57. 2%, CVRX: -75. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CVRX and LFST and LIVN and ACHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(CVRX: 9.8% · LFST: 21.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.